Market Overview

Visceral Pain | A Drug Pipeline Analysis Report 2018 | Technavio

Share:

Technavio has announced their latest report on drug pipeline analysis
for visceral
pain
. The report includes a detailed analysis of the pipeline
molecules under investigation within the defined data collection period
to treat visceral pain.

This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20180802005921/en/

Technavio has published a new report on the drug development pipeline for visceral pain, including a ...

Technavio has published a new report on the drug development pipeline for visceral pain, including a detailed study of the pipeline molecules. (Graphic: Business Wire)

This report by Technavio
presents a detailed analysis of the market, including regulatory
framework, drug development strategies, recruitment strategies, and key
companies that are expected to play an essential role in the growth of
the market in the future.

This report is available at a USD 1,000 discount for a limited time
only:
View
market snapshot before purchasing

Visceral pain: Market overview

Visceral pain is a type of nociceptive pain, which results from the
activation of nociceptors in thoracic, pelvic, or abdominal viscera
organs. Nociceptive pain is caused by an injury, physical pressure, or
inflammation of some part of the body. The treatment of visceral pain
includes analgesics, such as narcotics and NSAIDs, and pain modifiers
such as tricyclic antidepressants and anticonvulsants.

According to a senior market research analyst at Technavio, "Visceral
pain can be experienced in the trunk area of the body, including the
abdominal part, pelvic organs, heart, and lungs, owing to inflammation.
The pain is felt as generalized squeezing or aching in the body."

Visceral pain: Segmentation analysis

This pipeline analysis report segments the visceral pain market based on
therapies employed (monotherapy), RoA (oral), therapeutic modality
(small molecule and monoclonal antibody), targets (CB-2 receptor, GABAB
receptor, glutamate 2/3 receptor, homomeric hP2X3 and heteromeric
hP2X2/3 receptor, KCNQ channel, mGlu7 receptor, NaV1.7 voltage-gated
sodium ion channel, and P2X3 receptor), MoA (cannabinoid 2 receptor
agonist, GABAB receptor allosteric modulator, glutamate 2/3 receptor
agonist, homomeric hP2X3 and heteromeric hP2X2/3 receptor inhibitor,
mGlu7 receptor allosteric modulator, NaV1.7 voltage-gated sodium ion
channel antagonist, P2X3 receptor agonist, and sigma receptor agonist),
geographical segmentation (US) and recruitment status (recruiting). It
provides an in-depth analysis of the prominent factors influencing the
market, including drivers, opportunities, trends, and industry-specific
challenges.

Based on therapeutic modality, more than 67% of the molecules that are
being investigated for the treatment of visceral pain are small molecule.

Looking for more information on this market? Request
a free sample report

Technavio's sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Scope of the Report

Regulatory Framework

Drug Development Landscape

  • Drugs under development
  • Indications coverage

Drug Development Strategies

  • Therapies employed
  • RoA
  • Therapeutic modality
  • Geographical coverage

Recruitment Strategies

  • Recruitment status
  • Gender
  • Age

Key Companies

  • Type of players
  • Company overview

Discontinued or Dormant Molecules

About Technavio

Technavio
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio's comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team
at media@technavio.com.

View Comments and Join the Discussion!